Nestled in the heart of La Jolla, California, Kadima Neuropsychiatry offers patients a haven of relief amidst their chronic mental health challenges. The clinic specializes in dealing with treatment-resistant depression and other psychiatric conditions through the innovative use of ketamine therapy. Recognized by the World Health Organization as an essential medication, ketamine is a respected anesthetic that has shown increasingly promising results in treating resistant conditions. Moreover, Kadima Neuropsychiatry extends deep TMS therapy, which may be covered by insurance under certain conditions. Led by a team of seasoned healthcare professionals, including the founder Dr. David Feifel, a certified neuropsychiatric, the clinic is committed towards guiding its clients forward overcoming their mental health diseases, well represented by the word 'Kadima' meaning 'forward' in Hebrew.

Kadima Neuropsychiatry has been instrumental in helping patients reap the benefits of ketamine therapy, which serves as a viable alternative or complement to traditional treatments. Particularly for individuals who have seen minimal or no relief from conventional methods, the clinic's ketamine treatments offer a gleam of hope. This treatment is primarily intended for patients who, despite being generally healthy, have experienced a substantial negative impact on their lives due to treatment-resistant conditions. The clinic administers ketamine IV infusion therapy by directly infusing the drug into the bloodstream via an intravenous drip. Patients undergoing this therapy lie still in a serene setting. Post therapy, the positive effects are often immediate and can have lasting benefits for weeks. An induction series typically covers six infusions across two to three weeks. If the initial phase shows signs of improvements, patients then move onto a 'maintenance phase' with regular infusions every two to six weeks aiding their journey of sustained mental health improvement.